In silico validation of a new classifier, PCSCG ier , for predicting recurrence-free survival in prostate cancer patients: Evidence from multiple datasets.
Meng ZhangZichen BianJia ChenLei ChenJun ZhouQingsong NiuZongyao HaoJia-Lin MengChao-Zhao LiangPublished in: Clinical and translational medicine (2023)